Charter Oak Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Other funds holding HZNP
N
PC
ACA
Charter Oak Capital Management's HZNP Position: Q3 2022 in Review
Charter Oak Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2022, closing a stake of 66 shares — an estimated $5K sold.
Charter Oak Capital Management first reported a position in HZNP in Q1 2022 and held it in 2 quarters. The position peaked at $7K in Q1 2022. 530 funds tracked by Wall St. Rank hold HZNP as of Q3 2022.
- Charter Oak Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2022 after selling out during the quarter.
- Charter Oak Capital Management sold 66 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2022, an estimated $5K.
- Charter Oak Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2022 and held it in 2 quarters.
- Charter Oak Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $7K in Q1 2022.
- 530 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2022.
Based on Charter Oak Capital Management's 13F filing for Q3 2022, filed 6 Dec 2022.